n(6)-2-(4-amino-3-iodophenyl)ethyladenosine has been researched along with adenosine in 6 studies
| Studies (n(6)-2-(4-amino-3-iodophenyl)ethyladenosine) | Trials (n(6)-2-(4-amino-3-iodophenyl)ethyladenosine) | Recent Studies (post-2010) (n(6)-2-(4-amino-3-iodophenyl)ethyladenosine) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 32,536 | 1,075 | 8,930 |
| Protein | Taxonomy | n(6)-2-(4-amino-3-iodophenyl)ethyladenosine (IC50) | adenosine (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
| Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
| Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
| Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
| Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olah, M; Stiles, GL | 1 |
| Daly, DT; Olsson, RA; Stiles, GL | 2 |
| Stiles, GL | 1 |
| Brooks, R; Collis, MG; Keddie, JR; Poucher, SM; Shaw, GR | 1 |
| Bourgoin, S; Cesselin, F; Hamon, M; Mauborgne, A; Poliénor, H | 1 |
6 other study(ies) available for n(6)-2-(4-amino-3-iodophenyl)ethyladenosine and adenosine
| Article | Year |
|---|---|
Agonists and antagonists recognize different but overlapping populations of A1 adenosine receptors: modulation of receptor number by MgCl2, solubilization, and guanine nucleotides.
Topics: Adenosine; Animals; Cattle; Cell Membrane; Cerebral Cortex; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Kinetics; Magnesium Chloride; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Purinergic; Ultracentrifugation; Xanthines | 1990 |
The A1 adenosine receptor. Identification of the binding subunit by photoaffinity cross-linking.
Topics: Adenosine; Adipose Tissue; Affinity Labels; Animals; Binding, Competitive; Cell Membrane; Cerebral Cortex; Kinetics; Molecular Weight; Rats; Receptors, Cell Surface; Receptors, Purinergic | 1985 |
Photoaffinity cross-linked A1 adenosine receptor-binding subunits. Homologous glycoprotein expression by different tissues.
Topics: Adenosine; Adipose Tissue; Affinity Labels; Animals; Cell Membrane; Cerebral Cortex; Kinetics; Macromolecular Substances; Molecular Weight; Organ Specificity; Rats; Receptors, Cell Surface; Receptors, Purinergic | 1986 |
Characterization of the A1 adenosine receptor-adenylate cyclase system of cerebral cortex using an agonist photoaffinity ligand.
Topics: Adenosine; Adenylyl Cyclases; Affinity Labels; Animals; Azides; Cerebral Cortex; Iodine Radioisotopes; Kinetics; Male; Photochemistry; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic | 1986 |
In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist.
Topics: Adenosine; Animals; Cardiovascular Agents; Decerebrate State; Dogs; Female; Heart Rate; Hindlimb; In Vitro Techniques; Myocardial Contraction; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred SHR; Regional Blood Flow; Triazines; Triazoles; Vasodilation | 1996 |
Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Calcitonin Gene-Related Peptide; Cholecystokinin; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Neuropeptides; Pain; Phenethylamines; Potassium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Spinal Cord; Substance P; Xanthines | 2002 |